Capsula Closure vs. Non-Capsula Closure: Hip Arthroscopy in Danish Patients With Femoroacetabular Impingement (FAI)
Launched by AARHUS UNIVERSITY HOSPITAL · May 16, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a specific surgical technique affects patients with a hip condition called Femoroacetabular Impingement (FAI). The study compares two groups of patients who will undergo hip arthroscopy, which is a type of surgery to fix issues within the hip joint. One group will have their hip capsule closed at the end of the surgery, while the other group will have it left open. The goal is to see if those who have the capsule closed experience better recovery and improvement in their hip function and pain relief.
To be eligible for the trial, participants must be between the ages of 18 and 62 and have been diagnosed with FAI, with at least three months of physical therapy before considering surgery. However, individuals who have had previous hip surgeries, certain medical conditions like arthritis or cancer, or recent hip injuries are not eligible to participate. If you join this trial, you will help researchers understand the benefits of different surgical techniques, which could improve treatment for future patients with hip injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Radiological and symptomatic Femoroacetabular Impingement, where surgery is indicated. Preoperatively a minimum of 3 months of relevant physiotherapeutic treatment should have been performed.
- Exclusion Criteria:
- • Previous hip surgery in either hip
- • Malignant disease
- • Recent hip or pelvic fractures
- • Arthritic disease
- • Hip joint dysplasia
- • Legg-Calvé-Perthes
- • Slipped Capital Femoris Epiphysis
- • Recent (within 6 weeks) medical treatment with corticosteroids
- • Language problems of any kind
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials